Summary
Alloxan diabetes caused a decrease in cyclic AMP phosphodiesterase in all affected rat tissues. Cyclic GMP phosphodiesterase activity was, however, decreased in adipose and liver, but increased in heart and uterus.
Similar content being viewed by others
References
G. Senft, G. Schultz, K. Muske and M. Hoffmann, Diabetologia4, 322 (1968).
E. G. Loten and J. G. T. Sneyd, Biochem. J.120, 187 (1970).
P. D. R. House, P. Paulis and H. J. Weideman, Eur. J. Biochem.24, 429 (1972).
B. Zinman and C. H. Hollenberg, J. biol. Chem.249, 2182 (1974).
T. Kono, F. W. Robison and J. A. Sarver, J. biol. Chem.250, 7826 (1975).
V. Manganiello and M. Vaughan, J. biol. Chem.248, 7164 (1973).
J. A. Beavo, J. G. Hardman and E. W. Sutherland, J. biol. Chem.246, 3841 (1971).
W. G. Thompson and M. M. Appleman, Biochemistry10, 311 (1971).
T. R. Russell and I. H. Pastan, J. biol. Chem.249, 7764 (1974).
J. Londesborough, Analyt. Biochem.71, 623 (1976).
O. H. Lowry, N. J. Rosebrough, A. L., Farr and R. J. Randall, J. biol. Chem.193, 265 (1951).
E. G. Loten, F. Assimacopoulos-Jeannet, J. H. Exton and C. R. Park, J. biol. Chem.253, 746 (1978).
C. Correze, R. Auclair and J. Nunez, Molec. cell. Endocr.5, 67 (1976).
I. Das and E. B. Chain, Biochem. J.128, 95P (1972).
Author information
Authors and Affiliations
Additional information
This research was supported by U.S. Public Health Service grant RO1-AM19364-O1 and MARC training grant No. 1-TO2-GMO50000.
Rights and permissions
About this article
Cite this article
Perez de Gracia, B., Rhoads, A.R. & West, W.L. The response of cyclic 3′,5′-AMP and cyclic 3′,5′-GMP phosphodiesterases to experimental diabetes. Experientia 36, 824–825 (1980). https://doi.org/10.1007/BF01978592
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01978592